Soft Regulations in Pharmaceutical Policy Making: An Overview of Current Approaches and their Consequences

Author： Wettermark Björn   Godman Brian   Jacobsson Bengt  

Publisher： Adis International

ISSN： 1175-5652

Source： Applied Health Economics and Health Policy, Vol.7, Iss.3, 2009-09, pp. : 137-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The new pharmaceutical policy in Italy

By Fattore G.   Jommi C.  

Health Policy, Vol. 46, Iss. 1, 1998-10 ,pp. : 21-41

Elsevier

Access to resources Recommend Favorite

Regulations for Combined Effects of Pollutants: Consequences From Risk Assessment in Aquatic Toxicology

By Altenburger R.   Boedeker W.   Faust M.   Grimme L.H.  

Food and Chemical Toxicology, Vol. 34, Iss. 11, 1996-11 ,pp. : 1155-1157

Elsevier

Access to resources Recommend Favorite

Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview

By Almeida Hugo  

Expert Opinion on Drug Delivery, Vol. 10, Iss. 9, 2013-09 ,pp. : 1223-1237

Informa Healthcare

Access to resources Recommend Favorite

Dietary approaches to the control of vitamin A deficiency: An introduction and overview

By Underwood Barbara A.  

Food & Nutrition Bulletin, Vol. 21, Iss. 2, 2000-06 ,pp. : 117-123

Nevin Scrimshaw International Nutrition Foundation

Access to resources Recommend Favorite

Health policy versus industrial policy in the pharmaceutical sector: the case of Canada

By Vandergrift M.   Kanavos P.  

Health Policy, Vol. 41, Iss. 3, 1997-09 ,pp. : 241-260

Elsevier

Access to resources Recommend Favorite